shortagewatch

Home / Genito-urinary system and sex hormones / norgestimate and ethinylestradiol

ATC G03AB09 · Progestogens and Estrogens, Sequential Preparations

norgestimate and ethinylestradiol shortage

As of 2 Nov 2026, norgestimate and ethinylestradiol has a reported shortage in 1 of the 15 countries we track (Canada), covering 2 products from 1 company.

Countries1/15
Products2packs or presentations
Companies10 listed
Short since5 May 20266 months ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage

Timeline

Canada
TRI-CIRA 28 (28 BLS)TRI-CIRA 28 (28 BLS)TRI-CIRA 21 (21 BLS)TRI-CIRA 21 (21 BLS)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Apotex2

Compared with similar medicines

ATC group G03AB · Progestogens and Estrogens, Sequential Preparations
Desogestrel and Ethinylestradiol1/15Levonorgestrel and Ethinylestradiol1/15Progestogens and Estrogens, Sequential Preparations1/15norgestimate and ethinylestradiol1/15

Affected products

CountryProductCompanySinceExpected backReason
CATRI-CIRA 28 (28 BLS)APOTEX INC5 May 2026not givenManufacturing problem
Disruption of the manufacture of the drug
CATRI-CIRA 21 (21 BLS)APOTEX INC5 May 2026not givenManufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.